Aging- and Tumor-Mediated Increase in CD8+CD28- T Cells Might Impose a Strong Barrier to Success of Immunotherapy in Glioblastoma.
Huff WX, Bam M, Shireman JM, Kwon JH, Song L, Newman S, Cohen-Gadol AA, Shapiro S, Jones T, Fulton K, Liu S, Tanaka H, Liu Y, Wan J, Dey M.
Huff WX, et al. Among authors: shapiro s.
Immunohorizons. 2021 Jun 8;5(6):395-409. doi: 10.4049/immunohorizons.2100008.
Immunohorizons. 2021.
PMID: 34103370
Free PMC article.